AXSM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $5,805,082.51

Axsome Therapeutics Insider Trading History Chart

Axsome Therapeutics Share Price & Price History

^$86.53

▲ +0.55 (0.64%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

NEW AI developed by trader who won 1,129% (in 2 days)

From Monument Traders Alliance | Ad

Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans...

Click here to see how >>>

Axsome Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/29/2024	Mark L Jacobson	COO	Sell	7,910	$74.31	$587,792.10	5,783
5/28/2024	Mark Coleman	Director	Sell	5,249	$75.21	$394,777.29	19,848
4/1/2024	Mark L. Jacobson	COO	Sell	24,662	$77.24	$1,904,892.88
3/14/2024	Roger Jeffs	Director	Sell	29,976	$69.70	$2,089,327.20	120,756
9/15/2023	Mark Coleman	Director	Sell	11,016	$75.19	$828,293.04	25,097
11/19/2021	Roger Jeffs	Director	Buy	3,950	$37.30	$147,335.00
11/18/2021	Nick Pizzie	CFO	Buy	527	$35.50	$18,708.50
11/17/2021	Mark E. Saad	Director	Buy	3,000	$34.53	$103,590.00

This student turned $1,300 into $45,000 in just 4 Months!

From Monument Traders Alliance | Ad

With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.

See here to see the full details.

SEC Filings (Institutional Ownership Changes) for Axsome Therapeutics (NASDAQ:AXSM)

81.49% of Axsome Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Axsome Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/26/2024	Bank of New York Mellon Corp	165,564	$13.33M	0.0%	+7.7%	0.349%
7/26/2024	AlphaCentric Advisors LLC	15,000	$1.21M	0.9%	-53.8%	0.032%
7/20/2024	China Universal Asset Management Co. Ltd.	5,580	$0.45M	0.1%	-38.7%	0.012%
7/20/2024	Hennion & Walsh Asset Management Inc.	64,685	$5.21M	0.3%	-6.9%	0.136%
7/18/2024	Assenagon Asset Management S.A.	33,969	$2.74M	0.0%	N/A	0.072%
7/17/2024	Oak Ridge Investments LLC	13,936	$1.12M	0.1%	-12.5%	0.029%
7/16/2024	Flower City Capital	3,000	$0.24M	0.2%	N/A	0.006%
7/12/2024	Lion Street Advisors LLC	8,315	$0.67M	0.2%	-30.3%	0.018%
7/11/2024	Wesbanco Bank Inc.	13,300	$1.07M	0.0%	+60.2%	0.028%
7/10/2024	CWM LLC	23,920	$1.93M	0.0%	-19.2%	0.050%
7/5/2024	DNB Asset Management AS	6,072	$0.49M	0.0%	+37.2%	0.013%
5/28/2024	Teachers Retirement System of The State of Kentucky	9,698	$0.77M	0.0%	N/A	0.020%
5/17/2024	Artal Group S.A.	76,837	$6.13M	0.2%	N/A	0.162%
5/17/2024	Comerica Bank	9,067	$0.72M	0.0%	+7,716.4%	0.019%
5/17/2024	Alethea Capital Management LLC	740,791	$59.12M	48.0%	-1.5%	1.560%
5/17/2024	Castleark Management LLC	32,200	$2.57M	0.1%	N/A	0.068%
5/16/2024	California State Teachers Retirement System	31,251	$2.49M	0.0%	-5.8%	0.066%
5/16/2024	Kennedy Capital Management LLC	19,483	$1.56M	0.0%	+46.0%	0.041%
5/15/2024	Bellevue Group AG	685,476	$54.70M	0.8%	+7.9%	1.443%
5/15/2024	Price T Rowe Associates Inc. MD	25,274	$2.02M	0.0%	-82.8%	0.053%
5/15/2024	Hood River Capital Management LLC	520,750	$41.56M	0.9%	+32.6%	1.096%
5/15/2024	Affinity Asset Advisors LLC	139,758	$11.15M	1.4%	+179.5%	0.294%
5/14/2024	EntryPoint Capital LLC	437	$35K	0.0%	N/A	0.001%
5/14/2024	Natixis	1,235	$99K	0.0%	+13.6%	0.003%
5/14/2024	Pitcairn Co.	4,674	$0.37M	0.0%	-5.8%	0.010%
5/14/2024	Healthcare of Ontario Pension Plan Trust Fund	138,300	$11.04M	0.0%	N/A	0.291%
5/14/2024	CANADA LIFE ASSURANCE Co	7,370	$0.59M	0.0%	+136.8%	0.016%
5/14/2024	American International Group Inc.	17,570	$1.40M	0.0%	-0.9%	0.037%
5/13/2024	Clearbridge Investments LLC	89,370	$7.13M	0.0%	N/A	0.188%
5/11/2024	Covestor Ltd	1,097	$88K	0.1%	+54,750.0%	0.002%
5/10/2024	Vanguard Group Inc.	3,740,278	$298.47M	0.0%	+1.2%	7.875%
5/10/2024	Tocqueville Asset Management L.P.	6,300	$0.50M	0.0%	-6.0%	0.013%
5/9/2024	Blair William & Co. IL	63,547	$5.07M	0.0%	+645.9%	0.134%
5/9/2024	State Board of Administration of Florida Retirement System	9,422	$0.75M	0.0%	-6.2%	0.020%
5/8/2024	ProShare Advisors LLC	9,724	$0.78M	0.0%	+9.0%	0.020%
5/8/2024	US Bancorp DE	133,505	$10.65M	0.0%	-6.9%	0.281%
5/8/2024	Russell Investments Group Ltd.	791	$63K	0.0%	+5,550.0%	0.002%
5/7/2024	Sei Investments Co.	35,654	$2.85M	0.0%	+8.2%	0.075%
5/7/2024	SG Americas Securities LLC	15,104	$1.21M	0.0%	+605.5%	0.032%
5/2/2024	Mutual of America Capital Management LLC	41,620	$3.32M	0.0%	+20.4%	0.088%
5/2/2024	Iridian Asset Management LLC CT	128,842	$10.28M	2.0%	-6.9%	0.271%
5/1/2024	Janney Montgomery Scott LLC	5,780	$0.46M	0.0%	+9.5%	0.012%
5/1/2024	BNP Paribas Financial Markets	82,544	$6.59M	0.0%	+323.8%	0.174%
5/1/2024	Oak Ridge Investments LLC	15,930	$1.27M	0.1%	+2.7%	0.034%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	15,249	$1.22M	0.0%	-15.1%	0.032%
4/30/2024	Privium Fund Management B.V.	82,032	$6.55M	1.8%	+13.9%	0.173%
4/29/2024	Principal Financial Group Inc.	9,773	$0.78M	0.0%	+2.9%	0.021%
4/29/2024	China Universal Asset Management Co. Ltd.	9,103	$0.73M	0.1%	+66.3%	0.019%
4/26/2024	Peregrine Capital Management LLC	86,135	$6.87M	0.2%	+1.6%	0.182%
4/25/2024	Lindbrook Capital LLC	83,768	$6.69M	0.6%	-0.4%	0.177%
4/25/2024	WCM Investment Management LLC	111,590	$8.91M	0.0%	+6.5%	0.236%
4/23/2024	Wesbanco Bank Inc.	8,300	$0.66M	0.0%	N/A	0.018%
4/23/2024	Raymond James Financial Services Advisors Inc.	17,321	$1.38M	0.0%	-4.5%	0.037%
4/17/2024	Hennion & Walsh Asset Management Inc.	69,483	$5.55M	0.3%	+14.6%	0.147%
4/15/2024	Janiczek Wealth Management LLC	1,213	$97K	0.0%	N/A	0.003%
4/10/2024	Yarbrough Capital LLC	5,054	$0.40M	0.0%	N/A	0.011%
3/11/2024	Vanguard Group Inc.	3,696,766	$294.23M	0.0%	-0.9%	7.804%
3/5/2024	Wellington Management Group LLP	239,819	$19.09M	0.0%	+1.0%	0.506%
2/26/2024	Perceptive Advisors LLC	1,038,019	$82.62M	1.9%	+115.5%	2.194%
2/22/2024	Sierra Summit Advisors LLC	9,224	$0.73M	0.2%	N/A	0.019%
2/15/2024	PFM Health Sciences LP	467,427	$37.20M	2.2%	-10.7%	0.988%
2/15/2024	Great Point Partners LLC	4,963	$0.40M	0.1%	N/A	0.010%
2/15/2024	BVF Inc. IL	1,981,100	$157.68M	4.0%	-7.0%	4.187%
2/14/2024	Point72 Asset Management L.P.	837,201	$66.63M	0.2%	+57.4%	1.769%
2/14/2024	Avidity Partners Management LP	459,400	$36.56M	1.3%	+54.8%	0.971%
2/14/2024	Superstring Capital Management LP	16,179	$1.29M	0.9%	N/A	0.034%
2/14/2024	Bellevue Group AG	635,372	$50.57M	0.8%	+0.6%	1.343%
2/14/2024	Lighthouse Investment Partners LLC	56,202	$4.47M	0.2%	N/A	0.119%
2/13/2024	Affinity Asset Advisors LLC	50,000	$3.98M	0.7%	N/A	0.106%
2/13/2024	CIBC Private Wealth Group LLC	17,999	$1.43M	0.0%	+0.8%	0.038%
2/13/2024	Rhenman & Partners Asset Management AB	79,100	$6.30M	0.6%	+97.3%	0.167%
2/12/2024	TD Asset Management Inc	16,000	$1.27M	0.0%	N/A	0.034%
2/12/2024	Hsbc Holdings PLC	80,437	$6.37M	0.0%	-45.9%	0.170%
2/9/2024	US Bancorp DE	143,424	$11.42M	0.0%	+3.4%	0.303%
2/9/2024	Aigen Investment Management LP	3,866	$0.31M	0.1%	N/A	0.008%
2/9/2024	D.A. Davidson & CO.	7,240	$0.58M	0.0%	-2.6%	0.015%
2/9/2024	Norges Bank	195,123	$15.53M	0.0%	N/A	0.412%
2/8/2024	Meridian Wealth Management LLC	20,498	$1.63M	0.1%	+6.6%	0.043%
2/8/2024	Janney Montgomery Scott LLC	5,280	$0.42M	0.0%	-5.0%	0.011%
2/8/2024	Nicholas Investment Partners LP	82,645	$6.58M	0.8%	-79.1%	0.175%
2/8/2024	First Turn Management LLC	295,428	$23.51M	3.4%	N/A	0.624%
2/7/2024	Principal Financial Group Inc.	9,497	$0.76M	0.0%	+1.3%	0.020%
2/7/2024	Jump Financial LLC	8,400	$0.67M	0.0%	N/A	0.018%
2/7/2024	Dana Investment Advisors Inc.	13,641	$1.09M	0.1%	-3.6%	0.029%
2/7/2024	BNP Paribas Financial Markets	19,477	$1.55M	0.0%	-27.2%	0.041%
2/7/2024	Teacher Retirement System of Texas	7,188	$0.57M	0.0%	-22.4%	0.015%
2/6/2024	Charles Schwab Investment Management Inc.	295,701	$23.54M	0.0%	+2.0%	0.625%
2/6/2024	National Bank of Canada FI	600	$46K	0.0%	-99.0%	0.001%
2/6/2024	Amalgamated Bank	5,090	$0.41M	0.0%	-2.7%	0.011%
2/6/2024	Swiss National Bank	60,500	$4.82M	0.0%	-15.6%	0.128%
2/5/2024	Victory Capital Management Inc.	5,208	$0.42M	0.0%	-72.5%	0.011%
2/5/2024	Cannell & Co.	82,845	$6.59M	0.2%	-20.5%	0.175%
2/5/2024	AtonRa Partners	4,678	$0.37M	0.7%	-9.7%	0.010%
2/5/2024	Intrust Bank NA	2,846	$0.23M	0.0%	-11.0%	0.006%
2/2/2024	Truist Financial Corp	21,086	$1.68M	0.0%	N/A	0.045%
2/2/2024	State of New Jersey Common Pension Fund D	38,049	$3.03M	0.0%	+17.2%	0.080%
2/1/2024	New York State Common Retirement Fund	28,047	$2.23M	0.0%	+12.2%	0.059%
2/1/2024	Handelsbanken Fonder AB	7,700	$0.61M	0.0%	+13.2%	0.016%
2/1/2024	CWM LLC	38,371	$3.05M	0.0%	-4.4%	0.081%
2/1/2024	Lindbrook Capital LLC	84,086	$6.69M	0.7%	-0.3%	0.178%

Data available starting January 2016

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder; and Sunosi (solriamfetol), a medication indicated to the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. It is also developing AXS-05, which is in Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-07, an investigational medicine that has completed Phase III trials for the acute treatment of migraine; AXS-12, an investigational medicine, which is in Phase III trial to treat narcolepsy; AXS-14, a selective and potent norepinephrine reuptake inhibitor that has completed Phase III trial for the treatment of fibromyalgia and other conditions; and solriamfetol, a dual-acting dopamine and norepinephrine reuptake inhibitor, which has completed a Phase 2 trial for treating attention-deficit/hyperactivity disorder, and is in phase 2 major depressive, binge eating, and shift work disorder. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

Today's Range

Now: $86.53

$85.05

$86.93

50 Day Range

MA: $78.54

$71.07

$86.53

52 Week Range

Now: $86.53

$55.02

$98.40

Volume

262,192 shs

Average Volume

706,856 shs

Market Capitalization

$4.11 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26

Who are the company insiders with the largest holdings of Axsome Therapeutics?: Axsome Therapeutics' top insider investors include:
Roger Jeffs (Director)
Mark Coleman (Director)
Mark L Jacobson (COO)
Mark L Jacobson (COO)
Learn More about top insider investors at Axsome Therapeutics.
Who are the major institutional investors of Axsome Therapeutics?: Axsome Therapeutics' top institutional shareholders include:
Bank of New York Mellon Corp — 0.35%
Hennion & Walsh Asset Management Inc. — 0.14%
Assenagon Asset Management S.A. — 0.07%
CWM LLC — 0.05%
AlphaCentric Advisors LLC — 0.03%
Oak Ridge Investments LLC — 0.03%
Learn More about top institutional investors of Axsome Therapeutics stock.
Which institutional investors are selling Axsome Therapeutics stock?: During the last quarter, AXSM stock was sold by these institutional investors:
AlphaCentric Advisors LLC
CWM LLC
Hennion & Walsh Asset Management Inc.
Lion Street Advisors LLC
China Universal Asset Management Co. Ltd.
Oak Ridge Investments LLC
During the last year, company insiders that have sold Axsome Therapeutics company stock include:
Roger Jeffs (Director)
Mark Coleman (Director)
Mark L Jacobson (COO)
Mark L Jacobson (COO)
Learn More investors selling Axsome Therapeutics stock.
Which institutional investors are buying Axsome Therapeutics stock?: Within the previous quarter, AXSM stock was bought by institutional investors including:
Assenagon Asset Management S.A.
Bank of New York Mellon Corp
Wesbanco Bank Inc.
Flower City Capital
DNB Asset Management AS